Page last updated: 2024-08-21

pyrazines and cucurbitacin i

pyrazines has been researched along with cucurbitacin i in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, NR; Hoang, MD; Jung, SH; Kim, HJ; Lee, HJ; Lee, JJ; Lee, YK; Lim, MS; Nguyen-Pham, TN; Vo, MC	1

Trials

1 trial(s) available for pyrazines and cucurbitacin i

Article	Year
Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro. Experimental hematology, 2014, Volume: 42, Issue:4 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; CD8-Positive T-Lymphocytes; Cell Death; Cytokines; Dendritic Cells; Down-Regulation; Female; Humans; Male; Multiple Myeloma; Pyrazines; STAT3 Transcription Factor; Triterpenes; Tumor Cells, Cultured; Up-Regulation	2014

Article

Year

Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.

Experimental hematology, 2014, Volume: 42, Issue:4

Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; CD8-Positive T-Lymphocytes; Cell Death; Cytokines; Dendritic Cells; Down-Regulation; Female; Humans; Male; Multiple Myeloma; Pyrazines; STAT3 Transcription Factor; Triterpenes; Tumor Cells, Cultured; Up-Regulation

2014